https://www.selleckchem.com/pr....oducts/monastrol.htm
Results Driving behaviors were continuously monitored for a median of 29 months (range, 21-32). AME patients took fewer daily trips during the last vs. the first 6 months of observation, with a greater proportion of trips exceeding 10 miles. Compared to cognitively normal individuals, AME patients were more likely to experience hard braking events as recovery progressed. Despite this, no accidents were self-reported or captured by the data logger. Conclusion Driving behaviors can be continuously monitored in AME patients using non-inv